Bio-Rad Laboratories | BIO - Operating Profit


Bio-Rad Laboratories reported $72.6M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Abbott USD 1.36B 775M Sep/2026
Agilent USD 444M 45M Jun/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Bruker USD 69.6M 59.4M Jun/2026
Charles River Laboratories USD 119.89M 9K Jun/2026
Danaher USD 1.25B 118M Sep/2026
General Electric Aerospace USD 2.22B 338M Sep/2026
Illumina USD 260M 21M Jun/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Laboratory Of America USD 418M 38.7M Sep/2026
Merck USD 7.33B 6.49B Sep/2026
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quest Diagnostics USD 479M 20M Sep/2026
Repligen USD 24.31M 3.18M Sep/2026
Revvity USD 126.14M 43.36M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Siemens EUR 3.19B 508M Jun/2026
Standard Biotools USD -9.42M 12.51M Mar/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Tosoh JPY 31.18B 5.54B Jun/2026
Waters USD -86M 234M Jun/2026